Study to Demonstrate the Non-inferiority of Olmesartan Medoxomil Versus Candesartan Cilexetil in Reducing Blood B-type (or Brain) Natriuretic Peptide Levels at Week 24

Summary

This study will compare olmesartan medoxomil to candesartan cilexetil in reducing BNP, a prognostic biomarker of heart failure, at week 24

Timeline

Start

2008-06

Primary completion

2009-11

Completion

2009-11

Outcome

Outcome not reported

Stopped (Enrollment): “Lack of subject recruitment”

Drugs

Indications